Large Cap High Growth Potential

Ergebnisse

13

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

13 Unternehmen

	Unternehmen	Letzter Preis	7D Rückkehr	1J Rückkehr	Marktkapitalisierung	Analysten Ziel	Bewertung	Wachstum	Div. Rendite	Industrie
	ABVX	€100.40	-2.8%	45.9%	€9.4b	€138.97	1909.2	64.1%	n/a	Pharmaceuticals & Biotech
	DIM	€192.00	5.0%	10.0%	€18.7b	€232.64	63.8	21.1%	0.4%	Pharmaceuticals & Biotech
	SU	€299.20	1.8%	41.5%	€168.2b	€325.88	35.5	16.0%	1.4%	Capital Goods
	HO	€249.80	-3.8%	9.9%	€51.3b	€295.16	34.3	15.6%	1.6%	Capital Goods
	KER	€252.75	-2.8%	10.1%	€31.0b	€290.33	2.1	76.3%	1.2%	Consumer Durables
	AIR	€205.85	-1.1%	15.5%	€162.9b	€230.96	27.4	14.7%	1.6%	Capital Goods
	STMPA	€42.32	-3.6%	82.0%	€37.8b	€65.23	94.4	37.8%	0.7%	Semiconductors
	SAF	€350.40	0.4%	22.0%	€145.3b	€379.55	37.4	13.6%	1.0%	Capital Goods
	AC	€47.47	4.1%	10.6%	€11.0b	€54.94	48.0	20.5%	2.8%	Consumer Services
	AM	€291.80	-4.6%	7.1%	€22.5b	€357.71	22.4	16.3%	1.6%	Capital Goods
	ERF	€72.82	3.1%	11.8%	€12.6b	€72.53	26.9	18.0%	1.0%	Pharmaceuticals & Biotech
	OR	€387.20	1.2%	-3.5%	€206.1b	€417.54	32.7	10.0%	1.9%	Household
	RMS	€1,547.50	-2.2%	-27.0%	€162.1b	€1,869.82	35.9	10.8%	1.2%	Consumer Durables

Page 1 of 1